Fact CheckerSign in

NCT07064967Recruiting

Non-Helium Magnetoencephalography in Autism Spectrum Disorder

Non-Helium Magnetoencephalography for Identifying Neurobiological Features and Functional Biomarkers in Children With Autism Spectrum Disorder: An Observational Cohort Study

Source: ClinicalTrials.gov · Last updated 15 Jul 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The goal of this observational study is to learn how brain activity in children with autism spectrum disorder (ASD) differs from typical developing children using magnetoencephalography (MEG). The main questions this study aims to answer are: Do children with ASD show different patterns of neural oscillation compared to typically developing children? Can MEG identify specific brain features that help ASD diagnosis? Participants will undergo MEG scan in both resting and tasking state, and their brain activity will be analyzed for characteristic neural oscillations and connectivity patterns. This study may help develop better tools for early ASD diagnosis.

Status (registry)
Recruiting
Study type
Observational
Enrollment
80 (estimated)
First submitted
3 Jul 2025
Start date
5 Nov 2024
Primary completion date
31 Dec 2027
Lead sponsor
Guangzhou Women and Children's Medical Center
Diseases
Autism
NCT number
NCT07064967

What you commit to

  • Study type: Observational
  • Planned participants: 80
  • From 5 Nov 2024 to the primary completion date, 31 Dec 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Metallic implants that may interfere with MEG signal acquisition;
  • Current use of antipsychotic medications or sedatives.

Other illness

  • Comorbid neurological disorders, genetic syndromes, or severe developmental disabilities;

Who the study is looking for

  • Boys aged 6 to 12 years;
  • Diagnosis of Autism Spectrum Disorder meeting DSM-5 criteria;
  • Intelligence quotient (IQ) score \> 70 (assessed via Wechsler Intelligence Scale for Children or other validated cognitive test);
  • Sufficient compliance to participate in MEG experiments.

Age in the registry: 6 years to 12 years · Sex: Male · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Guangzhou Women and Children's medical center
Coordinator of this site? Confirm its status
GuangzhouChinaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.